Biggest News Aggregation in the World
📰 Acid Oxidizing Solution News

Acid Oxidizing Solution News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Acid Oxidizing Solution. Real-time updates on events, politics, business and more.

Adhoc: Relief Therapeutics Holding SA: Relief Therapeutics Announces Enrollment of First Three Patients in Proof-of-Concept Clinical Trial of RLF-TD011 for the Treatment of Epidermolysis Bullosa

Relief Therapeutics Holding SA / Key word(s): Study Relief Therapeutics Announces Enrollment of First Three Patients in Proof-of-Concept Clinical Trial of RLF-TD011 for the Treatment of Epidermolysis
Northwestern University United States Switzerland General Amy Paller Irina Koffler Catherine Day

Relief Therapeutics Announces IRB Approval of Investigator-Initiated Trial Evaluating RLF-TD011 as an Adjunctive Treatment for Cutaneous T-Cell Lymphom

Relief Therapeutics Announces IRB Approval of Investigator-Initiated Trial Evaluating RLF-TD011 as an Adjunctive Treatment for Cutaneous T-Cell Lymphom - read this article along with other careers information, tips and advice on BioSpace
United States Northwestern University Irina Koffler Catherine Day Alan Zhou Nermeen Varawalla

Adhoc: Relief Therapeutics Holding SA: Relief Therapeutics Announces IRB Approval of Investigator-Initiated Trial Evaluating RLF-TD011 as an Adjunctive Treatment for Cutaneous T-Cell Lymphom

Relief Therapeutics Holding SA / Key word(s): Study Relief Therapeutics Announces IRB Approval of Investigator-Initiated Trial Evaluating RLF-TD011 as an Adjunctive Treatment for Cutaneous T-Cell Lymphom
Switzerland General Northwestern University United States Irina Koffler Catherine Day Alan Zhou

Relief Therapeutics Announces IRB Approval of Investigator-Initiated Trial Evaluating RLF-TD011 as a

Relief Therapeutics Holding SA / Key word(s): Study17-Jan-2023 / 06:56 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Relief Therapeutics Announces IRB Approval of Investigator-Initiated Trial Evaluating RLF-TD011 as an Adjunctive...
Northwestern University United States Irina Koffler Catherine Day Alan Zhou Nermeen Varawalla

EQS-Adhoc: RELIEF THERAPEUTICS Holding AG: Relief Therapeutics Reports Two Publications of Positive Data on Nexodyn(R) AOS for Hard-to-Heal Ulcers

EQS Group-Ad-hoc: RELIEF THERAPEUTICS Holding AG / Key word(s): Scientific publication Relief Therapeutics Reports Two Publications of Positive Data on Nexodyn(R) AOS for Hard-to-Heal Ulcers 20-Oct-2021
Elia Ricci Michael Miller Jack Weinstein Advita Lifescience Gmb Pharma Research Eqs Group

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

EQS-Adhoc: RELIEF THERAPEUTICS Holding AG: Relief's Subsidiary, APR Applied Pharma Research, Reports Data Published in Journal of Wound Care, Indicating Nexodyn(R) AOS Highly Effective Treatment to Support Healing of Hard-to-Heal Leg Ulcers

EQS Group-Ad-hoc: RELIEF THERAPEUTICS Holding AG / Key word(s): Scientific publication Relief's Subsidiary, APR Applied Pharma Research, Reports Data Published in Journal of Wound Care, Indicating
Michael Miller Jack Weinstein Advita Lifescience Gmb Robert Strohal Pharma Research Eqs Group

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science